![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
Lantheus
LNTH
Hutchmed (China)
HCM
Workday
WDAY
DexCom
DXCM
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
US Stock MarketDetailed Quotes
JELD JELD-WEN Holding
- 5.790
- -0.100-1.70%
Close Feb 26 16:00 ET
- 6.040
- +0.250+4.32%
Pre 06:27 ET
491.28MMarket Cap-2.61P/E (TTM)
5.980High5.770Low881.74KVolume5.890Open5.890Pre Close5.15MTurnover1.05%Turnover RatioLossP/E (Static)84.85MShares21.75052wk High0.79P/B485.97MFloat Cap5.62052wk Low--Dividend TTM83.93MShs Float42.270Historical High--Div YieldTTM3.56%Amplitude5.620Historical Low5.841Avg Price1Lot Size
JELD-WEN Holding Stock Forum
Sign in to post a comment
$JELD-WEN Holding (JELD.US)$
lot of buying some turtle creek bought a million shares at 10
$Tile Shop (TTSH.US)$ same here
lot of buying some turtle creek bought a million shares at 10
$Tile Shop (TTSH.US)$ same here
1
2
The trend of lower returns on the same capital suggests it's not a growth stock. The declining ROCE and stagnant capital employed could indicate a mature business facing new competition or smaller margins.
1
Insider selling at JELD-WEN Holding, even below the current price, may worry investors. The absence of insider buying in the past year doesn't convey optimism about the stock. Yet, moderate insider ownership shows some alignment between management and smaller shareholders.
JELD-WEN's ROE is below industry average and its high debt levels could signal risk. The company's reliance on debt to boost ROE is less satisfactory due to its sub-par returns.
JELD-WEN Holding's stable ROCE suggests a mature operation without promising substantial growth. The stock's 41% decline over five years questions the prospect for these trends to improve soon, making the company a less attractive option for potential multi-bagger returns.
Gapping up
In reaction to earnings/guidance:
• $ChargePoint (CHPT.US)$ +2.8%, $Designer Brands (DBI.US)$ +1.8%, $Donaldson (DCI.US)$ +0.7%
Other news:
• $Cepton(Delisted) (CPTN.US)$ +9.2% (receives non-bindingLolfor a $100mln investment from Koito Manufacturing)
• $Sorrento Therapeutics (SRNE.US)$ +7.2% (receives FDA Fast Track Designation for SP-103(Lidocaine Topical System) 5.4%)
• $Mereo BioPharma (MREO.US)$ +6.7% (sends letter to Rubric Capital...
In reaction to earnings/guidance:
• $ChargePoint (CHPT.US)$ +2.8%, $Designer Brands (DBI.US)$ +1.8%, $Donaldson (DCI.US)$ +0.7%
Other news:
• $Cepton(Delisted) (CPTN.US)$ +9.2% (receives non-bindingLolfor a $100mln investment from Koito Manufacturing)
• $Sorrento Therapeutics (SRNE.US)$ +7.2% (receives FDA Fast Track Designation for SP-103(Lidocaine Topical System) 5.4%)
• $Mereo BioPharma (MREO.US)$ +6.7% (sends letter to Rubric Capital...
9
5
Upgrades
• $Fortinet (FTNT.US)$ : BMO Capital Upgrades to Outperform from Market Perform - PT $350 (from $325)
• $Microchip Technology (MCHP.US)$ : Stifel Upgrades to Buy from Hold - PT $75 (from $70)
• $Ovintiv (OVV.US)$ : JPMorgan Upgrades to Overweight from Neutral - PT $64 (from $56)
• $Riot Platforms (RIOT.US)$ : Compass Point Upgrades to Buy from Neutral - PT $14 (from $30)
• $Snowflake (SNOW.US)$ : Jefferies Upgrades to Buy f...
• $Fortinet (FTNT.US)$ : BMO Capital Upgrades to Outperform from Market Perform - PT $350 (from $325)
• $Microchip Technology (MCHP.US)$ : Stifel Upgrades to Buy from Hold - PT $75 (from $70)
• $Ovintiv (OVV.US)$ : JPMorgan Upgrades to Overweight from Neutral - PT $64 (from $56)
• $Riot Platforms (RIOT.US)$ : Compass Point Upgrades to Buy from Neutral - PT $14 (from $30)
• $Snowflake (SNOW.US)$ : Jefferies Upgrades to Buy f...
17
1
15
Upgrades
• $Brixmor Property Group Inc (BRX.US)$ : JPMorgan Upgrades to Overweight from Neutral - PT $25 (from $27)
• $Cigna Group (CI.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $296 (from $283)
• $Enerpac Tool (EPAC.US)$ : Wells Fargo Upgrades to Overweight from Equal Weight - PT $23 (from $22)
• $Equity Residential (EQR.US)$ : RBC Capital Upgrades to Outperform from Sector Perform - PT $79 (from $95)
• $Extra Space Storage Inc (EXR.US)$ : JPMorga...
• $Brixmor Property Group Inc (BRX.US)$ : JPMorgan Upgrades to Overweight from Neutral - PT $25 (from $27)
• $Cigna Group (CI.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $296 (from $283)
• $Enerpac Tool (EPAC.US)$ : Wells Fargo Upgrades to Overweight from Equal Weight - PT $23 (from $22)
• $Equity Residential (EQR.US)$ : RBC Capital Upgrades to Outperform from Sector Perform - PT $79 (from $95)
• $Extra Space Storage Inc (EXR.US)$ : JPMorga...
15
1
2
Gainers：
• $Innoviz Technologies (INVZ.US)$ +18.7% (selected by "large automotive group manufacturer" to become its direct LiDAR supplier across multiple brands)
• $Hilltop Holdings (HTH.US)$ +15.7% (commenced a modified "Dutch auction" tender offer to purchase for cash up to $400 mln of its common stock at a price per share not less than $28,00 and not greater than $32.00 less any applicable withholding taxes and without interest usin...
• $Innoviz Technologies (INVZ.US)$ +18.7% (selected by "large automotive group manufacturer" to become its direct LiDAR supplier across multiple brands)
• $Hilltop Holdings (HTH.US)$ +15.7% (commenced a modified "Dutch auction" tender offer to purchase for cash up to $400 mln of its common stock at a price per share not less than $28,00 and not greater than $32.00 less any applicable withholding taxes and without interest usin...
18
3
2
No comment yet
Tonyco : Very oversold and undervalued:
Ultratech OP Tonyco : all time low. but like I always say....anticipate it going lower first cuz that's what happens after you buy. in short term it's already high...unless it's a breakout but in long term it's gone from 6-30 before anyway